Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the syntax trial

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 5, 2013, Pages 1006-1013

  Kappetein, Arie Pieter ^a   Head, Stuart J ^a   Morice, Marie Claude ^b   Banning, Adrian P ^c   Serruys, Patrick W ^a   Mohr, Friedrich Wilhelm ^d   Dawkins, Keith D ^e   Mack, Michael J ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSTITUT HOSPITALIER JACQUES CARTIER   (France)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^e BOSTON SCIENTIFIC CORPORATION   (United States)

^f The Heart Hospital   (United States)

Author keywords

Coronary artery bypass grafting; Diabetes; Percutaneous coronary intervention; SYNTAX

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; PACLITAXEL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GRAFT OCCLUSION; HEART INFARCTION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; STENT THROMBOSIS; SYNTAX SCORE;

AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84876826419     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt017     Document Type: Article

References (25)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31-40.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
3. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009;373: 1190-7.
4. Roffi M, Angiolillo DJ, Kappetein AP. Current concepts on coronary revascularization in diabetic patients. Eur Heart J 2011;32:2748-57.
5. Onuma Y, Wykrzykowska JJ, Garg S, Vranckx P, Serruys PW. ARTS I and II Investigators. 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials. JACC Cardiovasc Interv 2011;4:317-23.
6. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
7. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Stahle E et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year followup of the SYNTAX trial. Eur Heart J 2011;32:2125-34.
8. Banning AP, Westaby S, Morice M-C, Kappetein AP, Mohr FW, Berti S et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 2010;55:1067-75.
9. Mack MJ, Banning AP, Serruys PW, Morice MC, Taeymans Y, Van Nooten G et al. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg 2011;92:2140-6.
10. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006;151:1194-204.
11. Head SJ, Kaul S, Mack MJ, Serruys PW, Taggart DP, Holmes DR Jr et al. The rationale for heart team decision-making for patients with stable complex coronary artery disease. Eur Heart J 2012; 10.1093/eurheartj/eht059.
12. Head SJ, Holmes DR Jr, Mack MJ, Serruys PW, Mohr FW, Morice M et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc Interv 2012;5:618-25.
13. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.
14. The BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-6.
15. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118: 1146-54.
16. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schomig A et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 2008;337:a1331.
17. Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D et al. ARTS II Investigators. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol 2008;52:1957-67.
18. Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 2010;55:432-40.
19. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375-84.
20. Mohr FW, Rastan AJ, Serruys PW, Kappetein AP, Holmes DR, Pomar JL et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg 2011;141:130-40.
21. Head SJ, Mack MJ, Holmes DR Jr, Mohr FW, Morice MC, Serruys PW et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg 2012;41:535-41.
22. Farooq V, Vergouwe Y, Räber L, Vranckx P, Garcia-Garcia H, Diletti R et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J 2012;33:3098-104.
23. Park K, Park KW, Rha SW, Bae JH, Hur SH, Park JS et al. Comparison of 5-year clinical outcomes between sirolimus-versus paclitaxel-eluting stent: Korean multicenter network analysis of 9000-patient cohort. Circ Cardiovasc Interv 2012;5:174-84.
24. Stone GW, Kedhi E, Kereiakes DJ, Parise H, Fahy M, Serruys PW et al. Differential clinical responses to everolimus-eluting and Paclitaxeleluting coronary stents in patients with and without diabetes mellitus. Circulation 2011;124:893-900.
25. National Cholesterol Education Program Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.